OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s ...

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals.

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Chairman and CEO Phillip Frost reported that OPKO Health is advancing its strategic initiatives, highlighting the pending sale of BioReference Health's oncology and related clinical testing business ...

If you're just easing into investing, many top brokerages offer free stock-trading platforms that can get you started with zero-commission trading and no account minimums. CNBC Select has chosen the ...

FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 FDA alignment and regulatory strategy for EB613 ...

Even Wall Street takes days off. The regular schedule for the New York Stock Exchange and Nasdaq is Monday through Friday from 9:30 a.m. to 4 p.m. Eastern time with weekends off. There are also ...

Microsoft's partnership with OpenAI provides exposure to ChatGPT via investing in MSFT stock. Nvidia's dominant role in AI chip production offers a strong investment avenue through NVDA stock.